Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1

Overview

Journal Sci Rep

Specialty Science

Date 2018 Jul 4

PMID 29968758

Citations 9

Authors

Elisabeth Rexen Ulven

Mette Trauelsen

Matjaz Brvar

Michael Luckmann

Line O Bielefeldt

Lisa K I Jensen

Thue W Schwartz

Thomas M Frimurer

Affiliations

Soon will be listed here.

Abstract

The succinate receptor 1 (SUCNR1) is a receptor for the metabolite succinate, which functions as a metabolic stress signal in the liver, kidney, adipose tissue and the retina. However, potent non-metabolite tool compounds are needed to reveal the physiological role and pharmacological potential of SUCNR1. Recently, we published the discovery of a computationally receptor-structure derived non-metabolite SUCNR1 agonist series with high target selectivity. We here report our structure-activity exploration and optimisation that has resulted in the development of agonists with nanomolar potency and excellent solubility and stability properties in a number of in vitro assays. Ligand-guided receptor models with high discriminative power between binding of active and inactive compounds were developed for design of novel chemotypes.

Citing Articles

Roles of sensory receptors in non-sensory organs: the kidney and beyond.

Xu J, Shepard B, Pluznick J Nat Rev Nephrol. 2025; .

PMID: 39753689 DOI: 10.1038/s41581-024-00917-y.

Cellular succinate metabolism and signaling in inflammation: implications for therapeutic intervention.

Huang H, Li G, He Y, Chen J, Yan J, Zhang Q Front Immunol. 2024; 15:1404441.

PMID: 38933270 PMC: 11200920. DOI: 10.3389/fimmu.2024.1404441.

Molecular basis of ligand recognition and activation of the human succinate receptor SUCR1.

Li C, Liu H, Li J, He X, Zhu H, Fu W Cell Res. 2024; 34(8):594-596.

PMID: 38834763 PMC: 11291503. DOI: 10.1038/s41422-024-00984-7.

Development and Characterization of Potent Succinate Receptor Fluorescent Tracers.

Ciba M, Dibnah B, Hudson B, Rexen Ulven E J Med Chem. 2023; 66(13):8951-8974.

PMID: 37318348 PMC: 10350927. DOI: 10.1021/acs.jmedchem.3c00552.

Discovery of Potent Tetrazole Free Fatty Acid Receptor 2 Antagonists.

Valentini A, Schultz-Knudsen K, Hansen A, Tsakoumagkou A, Jenkins L, Christensen H J Med Chem. 2023; 66(9):6105-6121.

PMID: 37129317 PMC: 10547238. DOI: 10.1021/acs.jmedchem.2c01935.

References

Negoro N, Sasaki S, Mikami S, Ito M, Suzuki M, Tsujihata Y . Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist. ACS Med Chem Lett. 2014; 1(6):290-4. PMC: 4007909. DOI: 10.1021/ml1000855. View

Christiansen E, Due-Hansen M, Urban C, Grundmann M, Schroder R, Hudson B . Free fatty acid receptor 1 (FFA1/GPR40) agonists: mesylpropoxy appendage lowers lipophilicity and improves ADME properties. J Med Chem. 2012; 55(14):6624-8. DOI: 10.1021/jm3002026. View

He W, Miao F, Lin D, Schwandner R, Wang Z, Gao J . Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature. 2004; 429(6988):188-93. DOI: 10.1038/nature02488. View

Wittenberger T, Schaller H, Hellebrand S . An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors. J Mol Biol. 2001; 307(3):799-813. DOI: 10.1006/jmbi.2001.4520. View

Rubic T, Lametschwandtner G, Jost S, Hinteregger S, Kund J, Carballido-Perrig N . Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat Immunol. 2008; 9(11):1261-9. DOI: 10.1038/ni.1657. View

Ariza A, Deen P, Robben J . The succinate receptor as a novel therapeutic target for oxidative and metabolic stress-related conditions. Front Endocrinol (Lausanne). 2012; 3:22. PMC: 3355999. DOI: 10.3389/fendo.2012.00022. View

Hill J . In vitro drug metabolism using liver microsomes. Curr Protoc Pharmacol. 2011; Chapter 7:Unit7.8. DOI: 10.1002/0471141755.ph0708s23. View

Sapieha P, Sirinyan M, Hamel D, Zaniolo K, Joyal J, Cho J . The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med. 2008; 14(10):1067-76. DOI: 10.1038/nm.1873. View

Rueda M, Totrov M, Abagyan R . ALiBERO: evolving a team of complementary pocket conformations rather than a single leader. J Chem Inf Model. 2012; 52(10):2705-14. PMC: 3478405. DOI: 10.1021/ci3001088. View

10.

Norn C, Hauge M, Engelstoft M, Kim S, Lehmann J, Jones R . Mutation-Guided Unbiased Modeling of the Fat Sensor GPR119 for High-Yield Agonist Screening. Structure. 2015; 23(12):2377-2386. DOI: 10.1016/j.str.2015.09.014. View

11.

Bhuniya D, Umrani D, Dave B, Salunke D, Kukreja G, Gundu J . Discovery of a potent and selective small molecule hGPR91 antagonist. Bioorg Med Chem Lett. 2011; 21(12):3596-602. DOI: 10.1016/j.bmcl.2011.04.091. View

12.

Gogsig T, Sobjerg L, Lindhardt A, Jensen K, Skrydstrup T . Direct vinylation and difluorovinylation of arylboronic acids using vinyl- and 2,2-difluorovinyl tosylates via the Suzuki-Miyaura cross coupling. J Org Chem. 2008; 73(9):3404-10. DOI: 10.1021/jo7027097. View

13.

Luckmann M, Holst B, Schwartz T, Frimurer T . In Silico Investigation of the Neurotensin Receptor 1 Binding Site: Overlapping Binding Modes for Small Molecule Antagonists and the Endogenous Peptide Agonist. Mol Inform. 2016; 35(1):19-24. DOI: 10.1002/minf.201500080. View

14.

Michino M, Abola E, Brooks 3rd C, Dixon J, Moult J, Stevens R . Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008. Nat Rev Drug Discov. 2009; 8(6):455-63. PMC: 2728591. DOI: 10.1038/nrd2877. View

15.

Regard J, Sato I, Coughlin S . Anatomical profiling of G protein-coupled receptor expression. Cell. 2008; 135(3):561-71. PMC: 2590943. DOI: 10.1016/j.cell.2008.08.040. View

16.

Aguiar C, Rocha-Franco J, Sousa P, Santos A, Ladeira M, Rocha-Resende C . Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation. Cell Commun Signal. 2014; 12:78. PMC: 4296677. DOI: 10.1186/s12964-014-0078-2. View

17.

Trauelsen M, Rexen Ulven E, Hjorth S, Brvar M, Monaco C, Frimurer T . Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR91. Mol Metab. 2017; 6(12):1585-1596. PMC: 5699910. DOI: 10.1016/j.molmet.2017.09.005. View

18.

Due-Hansen M, Pandey S, Christiansen E, Andersen R, Hansen S, Ulven T . A protocol for amide bond formation with electron deficient amines and sterically hindered substrates. Org Biomol Chem. 2015; 14(2):430-433. DOI: 10.1039/c5ob02129d. View

19.

Correa P, Kruglov E, Thompson M, Leite M, Dranoff J, Nathanson M . Succinate is a paracrine signal for liver damage. J Hepatol. 2007; 47(2):262-9. PMC: 1986575. DOI: 10.1016/j.jhep.2007.03.016. View

20.

Katritch V, Rueda M, Lam P, Yeager M, Abagyan R . GPCR 3D homology models for ligand screening: lessons learned from blind predictions of adenosine A2a receptor complex. Proteins. 2010; 78(1):197-211. PMC: 2805832. DOI: 10.1002/prot.22507. View